Sientra, Inc.

111 articles with Sientra, Inc.

• Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue Reconstruction

  3/22/2023

  Aziyo Biologics, Inc. and Sientra, Inc. today announced they have entered into an agreement to expand the distribution of Aziyo’s SimpliDerm product line.

• Sientra to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023

  3/20/2023

  Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the fourth quarter and full year of 2022 after the close of trading on Thursday, March 30, 2023.

• Sientra Announces Preliminary Results from Clinical Study and The First Shipment of Viality™ Fat Transfer SystemData Supports Enhanced Viability of Fat in Breast Augmentation and Reconstruction Using the Viality System

  3/1/2023

  Sientra, Inc., a medical aesthetics company uniquely focused on plastic surgeons, announced that it has begun commercial shipping of its Viality™ with AuraClens™ fat transfer system.

• Sientra Announces 1-for-10 Reverse Stock Split

  1/20/2023

  Sientra, Inc., a medical aesthetics company uniquely focused on plastic surgeons, announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company’s issued and outstanding common stock.

• Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - December 29, 2022

  12/29/2022

  Sientra, Inc., a medical aesthetics company uniquely focused on plastic surgeons, announced that on December 27, 2022, the Company approved equity award grants under the Sientra Inc. Inducement Plan to 13 new employees.

• SIENTRA ANNOUNCES LAUNCH OF VIALITY™, A NOVEL FAT TRANSFER SYSTEM

  12/5/2022

  Sientra, Inc., a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery launched the Viality lipoaspirate wash system at the Beauty Through Science meeting in NYC this past Saturday.

• Sientra Reports Record Third Quarter 2022 Financial Results

  11/10/2022

  Sientra, Inc., a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced its financial results for the third quarter that ended September 30, 2022.

• Sientra to Report Third Quarter 2022 Financial Results on November 10, 2022

  10/31/2022

  Sientra, Inc., a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced that it will release financial results for the third quarter of 2022 after the close of trading on Thursday, November 10, 2022.

• Sientra Announces Pricing of $13.2 Million Public Offering

  10/21/2022

  Sientra, Inc. today announced the pricing of its previously announced underwritten public offering of 34,782,600 shares of its common stock (or common stock equivalents) and accompanying warrants to purchase up to an aggregate of 34,782,600 shares of common stock.

• Sientra Announces Proposed Public Offering - October 18, 2022

  10/18/2022

  Sientra, Inc., a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced that it intends to offer and sell in an underwritten public offering, subject to market and other conditions, shares of common stock.

• Sientra Announces Preliminary Unaudited Third Quarter Financial Results and Signing of Senior Secured Loan Facilities With Deerfield Management

  10/12/2022

  Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced preliminary unaudited financial results for the third quarter 2022.

• Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - September 06, 2022

  9/6/2022

  Sientra, Inc., a medical aesthetics company uniquely focused on plastic surgeons, announced that on August 29, 2022, the Company approved equity award grants under the Sientra Inc. Inducement Plan to 49 new employees.

• Sientra Reports Second Quarter 2022 Revenue Growth Driven By Increased Acceleration in Reconstruction Channel

  8/11/2022

  Sientra, Inc., a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced its financial results for the second quarter that ended June 30, 2022.

• Sientra to Report Second Quarter 2022 Financial Results on August 11, 2022

  7/28/2022

  Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the second quarter of 2022 after the close of trading on Thursday, August 11, 2022.

• Sientra Wins Premier’s Horizon Award for 2022 for Exceptional Customer Service, Engagement, and Value Creation

  7/11/2022

  Sientra, Inc., a leading medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, was recently honored with the 2022 Supplier Horizon Award.

• FDA Approves Sientra’s Low Plus Profile Projection Breast Implant

  7/6/2022

  Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) approved the Low Plus Profile Projection Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction.

• Sientra To Present At The William Blair 42nd Annual Growth Stock Conference

  5/23/2022

  Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), announced today its participation at the William Blair 42 nd Annual Growth Stock Conference , which takes place June 6-9, 2022.

• Sientra To Participate At The 19th Annual Craig-Hallum Institutional Investor Conference

  5/18/2022

  Sientra, Inc., announced its participation at the Virtual 19th Annual Craig-Hallum Institutional Investor Conference, which takes place June 1st, 2022.

• Sientra Reports Seventh Consecutive Quarter of Record Growth for First Quarter 2022

  5/12/2022

  Sientra, Inc., a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced its financial results for the first quarter that ended March 31, 2022.

• Sientra to Report First Quarter 2022 Financial Results on May 12, 2022

  5/3/2022

  Sientra, Inc., a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced that it will release financial results for the first quarter of 2022 after the close of trading on Thursday, May 12, 2022.